No More Dialysis

Immunologists Develop Method

To Decrease Rejections

Of Kidney Transplants

October 1, 2007 — A nephrologist has found that a specialized type of anti-rejection therapy using intravenous immunoglobulin can make kidney transplants possible for patients with high ‘anti-donor’ antibodies. 25 to 30 percent of patients on the kidney transplant list could benefit from this therapy. Tissue compatibility issues exist with any organ transplant, but the risk is greatly increased for those with high exposure to antigens received through blood transfusions, previous transplantation, or even pregnancy.

Seventy-thousand Americans are waiting for a kidney transplant. A third of them are parked on dialysis because their antibody levels are too high for a transplant. But that’s no longer a barrier for some people.

“I used to just sit around and throw up,” says former dialysis patient Soraya Kohanzadeh.

Dialysis is something Kohanzadeh would rather forget, but if telling her story saves lives, it’s worth it.

Kohanzadeh — like many kidney failure patients — developed high levels of “anti-donor” antibodies through blood transfusions. Her highly sensitized immune system would likely reject any donated kidney.

“Essentially, she would have a very short, sick life on dialysis,” says Joan Lando, Kohanzadeh’s mother.

But Kohanzadeh is no longer here, thanks to intravenous immunoglobulin therapy or IVIG. Here’s how it works: during dialysis, patients are given blood containing a mix of immunoglobulins, which “turn-off” the anti-donor antibodies’ attack response without suppressing the patient’s immune system.

“A significant other comes forward, donates an organ, and there’s an incompatibility there. We can treat the patient and remove those antibodies. Then the transplant can be done,” Stanley Jordan, M.D., director of nephrology at Cedars-Sinai Medical Center in Los Angeles.

More than a year after surgery, Lando’s kidney keeps her daughter alive.

“It was sort of shocking to think I wasn’t going to have to be sick forever,” Kohanzadeh says.

Through their website, this mother-daughter team works to spread the word of a little known therapy that could save thousands in need of a kidney. IVIG is covered by Medicare and can be used in both living and cadaver-donor transplants. Nearly 30 percent of patients on the kidney transplant list might benefit from this therapy.

To learn more go to www.sevenluckystars.com

1899 : Bayer patents aspirin

On this day in 1899, the Imperial Patent Office in Berlin registers Aspirin, the brand name for acetylsalicylic acid, on behalf of the German pharmaceutical company Friedrich Bayer & Co.

Now the most common drug in household medicine cabinets, acetylsalicylic acid was originally made from a chemical found in the bark of willow trees. In its primitive form, the active ingredient, salicin, was used for centuries in folk medicine, beginning in ancient Greece when Hippocrates used it to relieve pain and fever. Known to doctors since the mid-19thcentury, it was used sparingly due to its unpleasant taste and tendency to damage the stomach.

In 1897, Bayer employee Felix Hoffman found a way to create a stable form of the drug that was easier and more pleasant to take. (Some evidence shows that Hoffman’s work was really done by a Jewish chemist, Arthur Eichengrun, whose contributions were covered up during the Nazi era.) After obtaining the patent rights, Bayer began distributing aspirin in powder form to physicians to give to their patients one gram at a time. The brand name came from “a” for acetyl, “spir” from the spirea plant (a source of salicin) and the suffix “in,” commonly used for medications. It quickly became the number-one drug worldwide.
Aspirin was made available in tablet form and without a prescription in 1915. Two years later, when Bayer’s patent expired during the First World War, the company lost the trademark rights to aspirin in various countries. After the United States entered the war against Germany in April 1917, the Alien Property Custodian, a government agency that administers foreign property, seized Bayer’s U.S. assets. Two years later, the Bayer company name and trademarks for the United States and Canada were auctioned off and purchased by Sterling Products Company, later Sterling Winthrop, for $5.3 million.

Bayer became part of IG Farben, the conglomerate of German chemical industries that formed the financial heart of the Nazi regime. After World War II, the Allies split apart IG Farben, and Bayer again emerged as an individual company. Its purchase of Miles Laboratories in 1978 gave it a product line including Alka-Seltzer and Flintstones and One-A-Day Vitamins. In 1994, Bayer bought Sterling Winthrop’s over-the-counter business, gaining back rights to the Bayer name and logo and allowing the company once again to profit from American sales of its most famous product.

Sourced & published by Henry Sapiecha 17th March 2010

GENETICALLY ENGINEERED MONKEY

GLOWS IN THE DARK??

Oregon researchers have created the first genetically modified monkey. ANDi, a playful, coffee-colored rhesus monkey born on October 2nd 2000, has been engineered to carry a gene from another species. The work demonstrates that a foreign gene can be delivered and inserted into a primate chromosome. The researchers anticipate that gene insertions in the monkey will lead to primate models of human diseases—like Alzheimer’s, diabetes, heart disease and obesity—that will offer a more robust testing ground for new drugs, gene therapy and modified stem cells. ANDi (DNA inserted spelled backward) is the first transgenic monkey. “Our ultimate goal is to produce human disease models. Primates show human pathology better than mice, which, in many cases, are the only systems we have for modeling human diseases,” says Anthony Chan, of the Oregon Regional Primate Research Center, in Beaverton. The report is published in this week’s issue of Science. Chan’s goal was to show that a foreign gene can be inserted into a monkey’s chromosome and produce a functional protein. The GFP gene was chosen because the protein it produces emits a fluorescent green glow that can easily be seen through a microscope. Eventually scientists want to insert human disease genes and study disease progression in monkeys, says Chan. Tissue samples taken from ANDi’s cheek, hair, umbilical cord and placenta confirm that the cells contain the GFP gene and corresponding mRNA; the molecule that bridges the gap between DNA and protein. However, when the tissue was examined under the microscope, no green protein could be seen. “Maybe the quantity of protein is too small to be seen or maybe the mRNA is not being translated,” says Chan. The team will continue to monitor ANDi for GFP; Some transgenic animals do not produce any foreign protein until after the first year. (LEFT)Virus particles carrying the GFP gene are injected into the unfertilized egg. The gene (white) is released from the virus and incorporated into the chromosome. (RIGHT)About 6 hours after introducing the virus scientists artificially fertilize the egg by injecting a sperm from a male rhesus. The fertilized egg then begins to grow and divide. Two to three days later when the egg has divided twice and become a four-celled embryo it is implanted into a surrogate mother. Courtesy Oregon Regional Primate Research Cente VIEW THE LINK BELOW FOR MORE

• Introducing ANDi: The first genetically modified monkey
  Oregon researchers have created the first genetically modified monkey. ANDi, a playful, coffee-colored rhesus monkey born on October 2nd 2000, …
  www.genomenewsnetwork.org/articles/01_01/ANDi.shtml
• 
  
• Sourced and published by Henry Sapiecha 29th May 2009
• 
  

EPA bans carbofuran in food crops

WASHINGTON (UPI) — The U.S. Environmental Protection Agency has revoked all regulations permitting small amounts of the residue of carbofuran in food.

The EPA’s Monday decision was hailed by the American Bird Conservancy as marking “a huge victory for wildlife and the environment.”

The action involves a pesticide sold under the name “Furadan” by the FMC Corp. The EPA said the toxic insecticide does not meet current U.S. food safety standards. The EPA said its ruling will eliminate residues of carbofuran in food, including imports. Ultimately, the federal agency said, it will remove the pesticide from the market.

The conservancy said the agency’s announcement confirms a proposed action first announced in July. FMC Corp. will have 90 days to challenge the decision. Once the rule becomes final, the EPA will proceed with the cancellation of registration for all uses of the pesticide.

“Carbofuran causes neurological damage in humans, and one of the most deadly pesticides to birds left on the market,” said George Fenwick, president of the conservancy. “It is responsible for the deaths of millions of wild birds since its introduction in 1967, including Bald and Golden Eagles, Red-tailed Hawks and migratory songbirds. This EPA decision marks a huge victory for wildlife and the environment.”

The EPA said it was encouraging growers to “switch to safer pesticides or other environmentally preferable pest control strategies.”

Copyright 2009 by United Press International

Sourced and published by Henry Sapiecha 18thn May 2009

Airport sniffer dogs safe from

un-employment

The terrorism alert caused chaos at Heathrow Airport last week. But could new security technology prevent a repeat performance? (Image: Reuters/Toby Melville)

News Analysis No matter how sophisticated airport security technology becomes, it will probably never remove the need for sniffer dogs and bag searches, experts say.

The alleged foiled terrorist plot that affected flights between the UK and US last week has led to calls for newer, smarter security technology.

Devices on the horizon include insect-based sensors, wallpaper that sniffs out explosives as you walk past and smart closed-circuit TV that can pick a suspect out from a crowd or tell if you’ve left a bomb under a seat.

But Martin Cebis, whose company will present its all-in-one chemical sensing and surveillance system at an international military technology conference in the US next week, says would-be terrorists will probably always be one step ahead of technology.

“Ultimately you’re dealing with human ingenuity [and] you’re fighting a moving target and need to be able to adapt,” says Cebis, chief executive officer of Western Australia’s Embedded Technologies.

“I think you’ll still need searching and those kinds of things to occur.”

Cebis is also among a number of speakers who will brief security advisors and researchers in Canberra on the latest developments today.

Chemical sensing

One of the emerging areas of security, particularly in light of the alleged plot to carry liquid explosives onto planes, is in chemical sensing.

Associate Professor Adam McCluskey of the University of Newcastle is an Australian researcher developing chemical sensors based on drug design technology.

The sensors are can be “screen printed” onto fabrics, paper, plastics and even wallpaper.

“It’s basically a synthetic antibody,” he says.

“We’re applying drug design technology to generate polymeric scaffolds that specifically recognise the shape and electronics of the targeted molecule.”

The technique has been used to identify cocaine and heroin and is being developed to pick up chemicals like TNT and triacetone triperoxide, the chemical used in last year’s London Underground bombings.

“Instead of metal detectors we would have a bank of these sensors sucking the vapours off as you walk through,” he says.

He says while sniffer dogs will still be able to go places electronic noses can’t, sensing technology will be better able to detect specific substances.

Dr Michael Borgas, is an atmospheric scientist at CSIRO, which is developing an electronic nose to detect chemicals.

He says the future of airport chemical sensing lies in miniaturised devices.

Researchers at CSIRO are also looking to insects like fruit flies for inspiration.

“If you can understand how insects sense and act upon various volatile chemicals you’d hopefully be able to mimic that with electronic devices,” he says.

“What you want is a hand-held device that can suck in tiny bits of air and detect the molecules that are in that air. In airports you’d just stick it in a [passenger's] bag.”

Smart surveillance

Cebis says it will take more than high-tech chemical sensors, no matter how sensitive and discriminating they are.

“It’s fine to have sensors all over the place but you’ve got to be able to make intelligent decisions,” he says.

“The research challenge is to make cheap, sensitive, ubiquitous sensors coupled with smart surveillance technology.”

Cebis says closed-circuit TV will eventually be replaced by “smart” digital video technology that uses biometric identification and motion recognition to hone in on specific individuals and behaviour.

“They look at a scene and if there’s no motion they don’t film anything,” he says.

“Or a person may wander into a scene, deposit something and then move away. The fact that something was moving and now isn’t [will be picked up].”

Ting Shan of National ICT Australia (NICTA) will outline advances in face recognition technology at a security technology conference in Canberra next week.

Shan says new face recognition algorithms have been developed by NICTA and University of Queensland that aren’t befuddled by lighting, expression or angle of the face.

“It can synthesise a realistic frontal face image,” he says.

Impact of a new security environment

Borgas says while the events in the UK have highlighted advances in security technology, he doubts they will be implemented overnight.

McCluskey hopes it will give governments an impetus to provide the research and development funds to allow some of the more promising ideas to bear fruit.

“Sometimes it takes an event of this nature to provide a significantly high profile and the government willing to take a chance on the technology,” he says.

Cebis say all the technology in the world will never completely replace the most humble of checks.

“But whether they need to be as intrusive and time consuming as they currently are depends on the technology,” he says.

Sourced and published by Henry Sapiecha 13th May 2009

Beer helps scientists find

landmines

An ingredient of beer, brewer’s yeast, can ’smell’ explosives (Image: iStockphoto)(Source: iStockphoto)

Biotechnologists have genetically engineered brewer’s yeast to glow green in response to an ingredient found in landmines, a new study shows.

The study, published today online in the journal Nature Chemical Biology, shows the yeast can detect, or smell, airborne particles from explosives.

The scientists engineered the yeast Saccharomyces cerevisiae to sense molecules of the chemical DNT, or dinitrotoluene.

DNT is left over after making the explosive TNT, or trinitroluene. And dogs trained to sniff for explosives are believed in fact to be trained to detect DNT.

The scientists spliced a gene found in rats into the yeast’s genome so that the surface of its cells reacted in response to DNT.

To get a visual cue as to whether this ‘nose’ had detected DNT, the scientists also added a gene to turn the yeast a fluorescent green when contact was made.

The authors, led by Associate Professor Danny Dhanasekaran of Temple University School of Medicine in Philadelphia, believe they have found a useful, if so far experimental, type of biosensor.

These gadgets use organisms to detect environmental chemicals, including biological or chemical weapons.

In the past, scientists have shown that organisms such as moths and bees can detect explosives

Sourced and published by Henry Sapiecha 13th May 2009

Chocolate may cure coughs

Go on, have another bite (Image: iStockphoto)

An ingredient in chocolate could be used to stop persistent coughs and lead to more effective medicines, say U.K. researchers.

Their small study found that theobromine, found in cocoa, was nearly a third more effective in stopping persistent coughs than codeine, currently considered the best cough medicine.

The Imperial College London researchers, who published their results online in the FASEB Journal, said the discovery could lead to more effective cough treatments.

“While persistent coughing is not necessarily harmful it can have a major impact on quality of life, and this discovery could be a huge step forward in treating this problem,” said Professor Peter Barnes of Imperial College and Royal Brompton Hospital.

Ten healthy volunteers were given theobromine, codeine or a dummy pill during the trial.

Neither the volunteers nor the researchers knew who received which pill.

The researchers then measured levels of capsaicin, which is used in research to cause coughing and as an indicator for how well the medicines are suppressing coughs.

The team found when the volunteers were given theobromine, the concentration of capsaicin needed to produce a cough was around a third higher than in the placebo group.

When they were given codeine they needed only marginally higher levels of capsaicin to cause a cough compared with the placebo.

The researchers said that theobromine worked by suppressing vagus nerve activity, which is responsible for causing coughing.

They also found that unlike some standard cough treatments, theobromine caused no adverse effects on the cardiovascular or central nervous systems, such as drowsiness.

Dry coughs

The type of cough medicine someone takes depends on the type of cough they have.

Productive coughs, or coughs associated with phlegm, are treated with expectorants, drugs that help the body expel mucus from the respiratory tract.

But dry coughs are treated with antitussives, medicines that suppress the body’s urge to cough. And it is the antitussive class of cough medicines that the U.K. researchers looked at.

Antitussives can work centrally, via the brain, or peripherally, via the respiratory tract.

Codeine is one of the antitussives that acts centrally. But the researchers think that theobromine acts on the peripheral nervous system.

Theobromine is also a stimulant and belongs to the same class of molecule as caffeine.

While their chemical structures are similar, they have very different effects on the body. Theobromine is a mild, lasting stimulant that improves your mood while caffeine is stronger and acts very quickly to increase alertness.

Sourced and published by Henry Sapiecha 13th May 2009

TV may cure chocolate cravings

A flickering TV image may interfere with chocolate cravings, early research says (Image: iStockphoto)

Chocoholics might conquer their cravings by watching a flickering, untuned television for a few seconds, Australian research suggests.

Dr Eva Kemps and colleagues from Flinders University in Adelaide, publish their findings on the effect of random, flickering patterns on chocolate cravings in the February issue of the journal Eating Behaviors.

Cravings are triggered when people conjure up vivid mental images of a desired food or activity, Kemps says.

And these latest findings back the theory that looking at randomly flickering images interferes with the production of these vivid mental images. This would reduce their clarity, and so reduce the intensity of the cravings, she says.

While preliminary, Kemps says these findings may be “very comforting” and offer hope for people struggling with binge eating or obesity triggered by chocolate craving.

Another advantage, she says, is that watching a flickering image is more passive than high-energy distractions often recommended, like running.

“It is a tool people can use themselves … and not another one of those hard things [people with cravings] feel they have to do to deal with their eating problems,” she says.

Dreaming of chocolate

The researchers asked 48 female undergraduates to visualise images of chocolate cake, chocolate bars, chocolate pudding, chocolate ice cream, chocolate drinks, chocolate mousse or chocolate brownies.

Meanwhile, they were asked to look at a blank computer screen, or at a computer screen with randomly flickering black and white dots, for eight seconds.

Everyone in the study had a decrease in cravings when looking at the flickering images compared to when they looked at the blank computer screen.

But the reduction in chocolate cravings was more marked in people who admitted they craved chocolate compared with those who said they merely liked chocolate.

The researchers were surprised to find that listening to irrelevant speech in a foreign language reduced chocolate cravings too, but by not as much as the randomly flickering images.

Kemps believes the technique, which scientists know is useful for post-traumatic stress disorder and cigarette cravings, will ultimately help people conquer cravings in all types of addictions.

“But it’s probably not going to be all the treatment you are going to need,” she says.

Sourced and published by Henry Sapiecha 13th May 2009

Chocolate may deepen depression

Chocolate may give you short-term pleasure if you crave it. But it’s not an antidepressant, as many people think (Image: iStockphoto)

Chocoholics can happily eat chocolate for pleasure, but for those who are stressed and clinically depressed, the high is short-lived and chocolate may even deepen the downer, a review shows.

The findings, which will be published in the Journal of Affective Disorders, fly in the face of the myth that chocolate is an antidepressant.

The analysis, which is the most comprehensive literature review on how chocolate affects mood, shows that the motivation behind eating chocolate determines which neurotransmitters are activated, and hence your mood.

The review’s Australian authors, from the Black Dog Institute at the Prince of Wales Hospital in Sydney, identified two groups of chocolate eaters based on motivation.

They identified the cravers, who eat chocolate as an indulgent pleasure, and the emotional eaters, who use chocolate in a bid to alleviate depression.

Professor Gordon Parker, executive director of the Black Dog Institute and lead author, says cravers see chocolate like a good glass of wine, and anticipating and eating the treat releases ‘feel good’ neurotransmitters.

“Chocolate craving as an indulgent pleasure seems to stimulate the dopamine system in the brain, and provides an enjoyable experience,” he says.

“But the emotional eaters, people who eat chocolate to relieve boredom, stress or clinical depression, are looking for an opioid effect to improve their mood.”

For them, at best chocolate only provides temporary relief, he says. But this is quickly followed by a return to or a worsening of their earlier negative state.

Consuming sweet foods is thought to release the neurotransmitter beta-endorphin in the hypothalamus, which is said to have an opiate effect on the body.

But why the chocolate high is so transient and insufficient to sustain mood in those who eat it for emotional reasons remains unknown.

Busting the myth

The theory that chocolate acts as an antidepressant comes from the common belief that a serotonin deficiency causes chocolate cravings, but the review found no support for this hypothesis.

“It is true that chocolate acts on the same neurological system as serotonin. But you’d have to eat a truck load of chocolate before you have had the equivalent of one antidepressant tablet,” Parker says.

“Our review rejects any possibility that chocolate desired as a way of relieving stress or when feeling down has any antidepressant benefit.”

Stimulants such as caffeine, theobromine, tyramine and phenylethylamine, are also present in concentrations too low to have any significant psychoactive effect, the review says.

For more information about depression, including fact sheets, support and referrals, see the websites for beyondblue, Australia’s national depression initiative, and depressioNet.

Sourced and published by Henry Sapiecha 13th May 2009

Chocolate beer 3000 years old

People were enjoying chocolate 3000 years ago, but in the form of alcoholic brews or beers drunk at births and weddings (Source: iStockphoto)

People in Central America were drinking beverages made from cacao before 1000 BC, hundreds of years earlier than once thought, a new study shows.

These early cacao beverages were probably alcoholic brews, or beers, made from the fermented pulp of the cacao fruit.

These beverages were around 500 years earlier than the frothy chocolate-flavored drink made from the seed of the cacao tree that was such an important feature of later Mesoamerican culture.

But in brewing this primitive beer, or chicha, the ancient Mesoamericans may have stumbled on the secret to making chocolate-flavoured drinks, the paper says.

“In the course of beer brewing, you discover that if you ferment the seeds of the plant you get this chocolate taste,” says John Henderson, a professor of anthropology at Cornell University in Ithaca, New York, and lead author of the paper.

“It may be that the roots of the modern chocolate industry can be traced back to this primitive fermented drink.”

The cacao bean played an important role in Mesoamerican civilisation, the native civilisation in parts of Mexico and Central America prior to the Spanish exploration and conquest of the 16th century.

The bean was a form of currency in Aztec society, and the frothed chocolate drink made from fermented beans or seeds was central to social and ritual life throughout Mesoamerica.

In the 16th century, invading Europeans acquired a taste for the beverage and brought it back to Europe, which led to the rise of the modern chocolate industry.

An elite drink

The archaeological evidence recovered by Henderson and colleagues from a site in Puerto Escondido in modern-day Honduras suggests that the beer that probably preceded the chocolate beverage was popular among wealthy people at least as early as 1100 BC.

Chemical analysis of residues found on fragments of pottery vessels recovered from the site tested positive for theobromine, a compound found in cacao trees that were limited to Central America.

The vessels were found in the “fancier, bigger houses” in the village of Puerto Escondido in the Ulua Valley in northern Honduras, says Henderson.

He suggests the elite members of society would have drunk the beverage to mark special occasions such as births and marriages.